Knoechel et al., 2006 - Google Patents
Functional and molecular comparison of anergic and regulatory T lymphocytesKnoechel et al., 2006
View PDF- Document ID
- 10860859330557718105
- Author
- Knoechel B
- Lohr J
- Zhu S
- Wong L
- Hu D
- Ausubel L
- Abbas A
- Publication year
- Publication venue
- The Journal of Immunology
External Links
Snippet
Tolerance in vivo is maintained by multiple mechanisms that function to prevent autoimmunity. An encounter of CD4+ T cells with a circulating self-Ag leads to partial thymic deletion, the development of CD25+ regulatory T cells (Tregs), and functional anergy in the …
- 210000003289 regulatory T cell 0 title abstract description 54
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/5044—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
- G01N33/5047—Cells of the immune system
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues ; Not used, see subgroups
- C12N5/0602—Vertebrate cells
- C12N5/0634—Cells from the blood or the immune system
- C12N5/0636—T lymphocytes
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay
- G01N33/569—Immunoassay; Biospecific binding assay for micro-organisms, e.g. protozoa, bacteria, viruses
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/70503—Immunoglobulin superfamily
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Knoechel et al. | Functional and molecular comparison of anergic and regulatory T lymphocytes | |
Firth et al. | Nfil3-independent lineage maintenance and antiviral response of natural killer cells | |
Kragten et al. | Blimp‐1 induces and Hobit maintains the cytotoxic mediator granzyme B in CD8 T cells | |
D’Souza et al. | Essential role for IL-2 in the regulation of antiviral extralymphoid CD8 T cell responses | |
Rudak et al. | MAIT cell-mediated cytotoxicity: Roles in host defense and therapeutic potentials in infectious diseases and cancer | |
Schenkel et al. | IL-15–independent maintenance of tissue-resident and boosted effector memory CD8 T cells | |
Fahey et al. | Viral persistence redirects CD4 T cell differentiation toward T follicular helper cells | |
Buer et al. | Interleukin 10 secretion and impaired effector function of major histocompatibility complex class II–restricted T cells anergized in vivo | |
Marshall et al. | NKG2C/E marks the unique cytotoxic CD4 T cell subset, ThCTL, generated by influenza infection | |
Pöllinger et al. | Th17 cells, not IL-17+ γδ T cells, drive arthritic bone destruction in mice and humans | |
Löhning et al. | Long-lived virus-reactive memory T cells generated from purified cytokine-secreting T helper type 1 and type 2 effectors | |
Hendriks et al. | CD27 promotes survival of activated T cells and complements CD28 in generation and establishment of the effector T cell pool | |
Christensen et al. | CD11b expression as a marker to distinguish between recently activated effector CD8+ T cells and memory cells | |
Fujimoto et al. | The influence of excessive IL-6 production in vivo on the development and function of Foxp3+ regulatory T cells | |
Huntington et al. | NK cell maturation and peripheral homeostasis is associated with KLRG1 up-regulation | |
Auderset et al. | Notch signaling regulates follicular helper T cell differentiation | |
Liu et al. | Serine protease inhibitor 2A is a protective factor for memory T cell development | |
Slevin et al. | Lymphocyte activation gene (LAG)-3 is associated with mucosal inflammation and disease activity in ulcerative colitis | |
Zaph et al. | Persistence and function of central and effector memory CD4+ T cells following infection with a gastrointestinal helminth | |
Taqueti et al. | T-bet controls pathogenicity of CTLs in the heart by separable effects on migration and effector activity | |
Genovese et al. | Cell-mediated immunity in elite controllers naturally controlling HIV viral load | |
Di Rosa et al. | On the lifespan of virgin T lymphocytes | |
Yu et al. | Efficient induction of primary and secondary T cell-dependent immune responses in vivo in the absence of functional IL-2 and IL-15 receptors | |
Sharma et al. | Mucosal-associated invariant T cells develop an innate-like transcriptomic program in anti-mycobacterial responses | |
Zhou et al. | Role of STAT4 and STAT6 signaling in allograft rejection and CTLA4-Ig-mediated tolerance |